Intercell Reaches Commercial Stage In US: Japanese Encephalitis Vaccine Gets FDA Okay

First vaccine approval for Intercell in US brings a new player fully into the vaccine business; Austrian company has key partnerships pending with Merck, Novartis and Sanofi.